Joaquín
Casal Rubio
Complexo Hospitalario Universitario de Ourense
Orense, EspañaPublications in collaboration with researchers from Complexo Hospitalario Universitario de Ourense (8)
2022
2021
-
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group
Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415
2018
-
Real world data of nivolumab for previously treated non-small cell lung cancer patients: A Galician lung cancer group clinical experience
Translational Lung Cancer Research, Vol. 7, Núm. 3, pp. 404-415
2016
-
EGFR testing and clinical management of advanced NSCLC: A galician lung cancer group study (GGCP 048-10)
Cancer Management and Research, Vol. 8, pp. 11-20
2015
-
Erlotinib as second-line therapy for patients with advanced non-small-cell lung cancer and wild-type EGFR tumors
Journal of Analytical Oncology, Vol. 4, Núm. 3, pp. 94-101
2014
-
Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: Review of patient profile
Anti-Cancer Drugs, Vol. 25, Núm. 4, pp. 368-374
2012
-
First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients
Expert Opinion on Pharmacotherapy, Vol. 13, Núm. 10, pp. 1389-1396
2009
-
A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
Cancer Chemotherapy and Pharmacology, Vol. 64, Núm. 2, pp. 379-384